Next Article in Journal
Identifying Elastic Constants for PPS Technical Material When Designing and Printing Parts Using FDM Technology
Previous Article in Journal
Synthesis, Characterization and Testing of Antimicrobial Activity of Composites of Unsaturated Polyester Resins with Wood Flour and Silver Nanoparticles
Previous Article in Special Issue
Lactoferrin/Calcium Phosphate-Modified Porous Ti by Biomimetic Mineralization: Effective Infection Prevention and Excellent Osteoinduction
 
 
Article
Peer-Review Record

Use of Therapeutic Pathogen Recognition Receptor Ligands for Osteo-Immunomodulation

Materials 2021, 14(5), 1119; https://doi.org/10.3390/ma14051119
by Paree Khokhani 1,†, Nada R. Rahmani 1,†, Anne Kok 1, F. Cumhur Öner 1, Jacqueline Alblas 1, Harrie Weinans 1,2, Moyo C. Kruyt 1 and Michiel Croes 1,*
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Reviewer 3: Anonymous
Materials 2021, 14(5), 1119; https://doi.org/10.3390/ma14051119
Submission received: 2 February 2021 / Accepted: 22 February 2021 / Published: 27 February 2021
(This article belongs to the Special Issue Multifunctional Coatings for Bone Regenerative Medicine)

Round 1

Reviewer 1 Report

The manuscript has quite improved from the previous submission.
Therefore I think it can be accepted in the present form.

Congratulations for the work improvement.

Reviewer 2 Report

All concerns have been addressed.

The manuscript is ready to publish.

Reviewer 3 Report

The authors of the paper “Use of Therapeutic Pathogen Recognition Receptor Ligands for Osteo-immunomodulation” aimed to explore the response of human mesenchymal stem cells (hMSCs) and monocytes-key cells in bone regeneration- towards therapeutic pathogen recognition receptor (PRR) ligand stimulation. Therefore they have evaluated the effect of various synthetic PRR ligands on bone cell differentiation and inflammation: alkaline phosphatase (ALP) activity in hMSCs, osteoclastogenic response induced in monocytes measured by TRAP, inflammatory property of ligands by ELISA evaluation of pro and anti–inflammatory (TNF-alpha, IL-6, IL-8, IL-10) cytokines expression. Based on the complex investigation, nucleic acid-based ligands Poly (I:C) and CpG ODN C were found to increase early ALP activity and not interfering with osteoclasts formation process. Their pro-osteogenic action was associated with a mild pro-inflammatory cell response. Due to these osteo-immunomodulatory effects, nucleic-acid ligands can be promising candidates for multifunctional coatings.

The new form is better presented.

Back to TopTop